WallStreetZenWallStreetZen

NASDAQ: TELO
Telomir Pharmaceuticals Inc Stock Ownership - Who owns Telomir Pharmaceuticals?

OverviewEarningsDividendOwnership

Insider buying vs selling

Have Telomir Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Shore Trust Bay10% Owner2024-02-1349,000$7.00
$343.00kBuy
Shore Trust Bay10% Owner2024-02-1340,000$7.00
$280.00kBuy
Shore Trust Bay10% Owner2024-02-1349,000$7.00
$343.00kBuy

1 of 1

TELO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TELO insiders and whales buy or sell their stock.

TELO Shareholders

What type of owners hold Telomir Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Shore Trust Bay11.12%3,292,696$19.99MInsider
Christopher C. Chapman Jr.3.29%975,610$5.92MInsider
Craig Eagle1.65%487,805$2.96MInsider
Nathen Fuentes0.34%101,134$613.88kInsider
Blackrock Inc0.30%87,899$533.55kInstitution
Geode Capital Management LLC0.22%66,355$402.77kInstitution
Bank Of New York Mellon Corp0.17%50,165$304.50kInstitution
Talhia Tuck0.16%48,781$296.10kInsider
Hugh McColl Iii0.16%48,781$296.10kInsider
Bradley Kroenig0.16%48,781$296.10kInsider

1 of 3

TELO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TELO1.22%17.08%Net Buying
GALT10.74%89.26%Net BuyingNet Buying
AMLX44.30%55.70%Net BuyingNet Buying
STTK70.36%26.41%Net SellingNet Buying
SKYE3.34%96.66%Net BuyingNet Selling
View Top Biotech Stocks

Telomir Pharmaceuticals Stock Ownership FAQ

Who owns Telomir Pharmaceuticals?

Telomir Pharmaceuticals (NASDAQ: TELO) is owned by 1.22% institutional shareholders, 17.08% Telomir Pharmaceuticals insiders, and 81.70% retail investors. Shore Trust Bay is the largest individual Telomir Pharmaceuticals shareholder, owning 3.29M shares representing 11.12% of the company. Shore Trust Bay's Telomir Pharmaceuticals shares are currently valued at $19.99M.

If you're new to stock investing, here's how to buy Telomir Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.